What is the recommended administration frequency for Harvoni?

Harvoni, which contains the antiviral medications ledipasvir and sofosbuvir, is specifically designed for the treatment of chronic hepatitis C virus infection. The recommended administration frequency for Harvoni is once daily. This single daily dosing is convenient for patients, encouraging adherence to the treatment regimen. The once daily schedule allows for consistent blood levels of the medication while minimizing the complexity of the treatment protocol.

Other dosing frequencies, such as twice daily, every other day, or weekly, would not provide the necessary constant therapeutic levels to effectively combat the virus, potentially leading to suboptimal treatment outcomes and increased risk of viral resistance. This streamlined dosing is one of the significant advantages of Harvoni, contributing to its popularity in hepatitis C therapy.